The Freshness Index shows the percentage of company sales generated by products launched in the last three and five years. A measure of a company’s ability to “refresh” its portfolio in the face of patent loss, providing a comprehensive portfolio.

The ‘freshness’ of revenue is one part of the matrix of data that goes into the annual Pharmaceutical Innovation & Invention Index, produced by IDEA Pharma and SAI. The 15th annual set of results will launch on May the 19th.

Stay tuned for the full results, launching at https://www.ideapharma.com/pii/report/global/